Acta Diabetologica

, Volume 56, Issue 2, pp 241–243 | Cite as

Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity

  • Matteo MonamiEmail author
  • Antonio Silverii
  • Edoardo Mannucci
Short Communication


Compliance with ethical standards

Conflict of interest

Matteo Monami has received speaking fees from Bristol Myers Squibb, Eli-Lilly, Merck, Novonordisk, Merck, and Takeda, and research grants from Bristol Myers Squibb. Antonio Silverii has no conflict of interests. Edoardo Mannucci has received consultancy fees from Merck and Novartis, speaking fees from Astra Zeneca, Bristol Myers Squibb, Merck, and Novartis, and research grants from Merck, Novartis, and Takeda.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study formal consent is not required.


  1. 1.
    Relton C, Cooper K, Viksveen P, Fibert P, Thomas K (2017) Prevalence of homeopathy use by the general population worldwide: a systematic review. Homeopathy 106:69–78CrossRefGoogle Scholar
  2. 2.
    To KLA, Fok YYY, Chong KCM, Lee YCJ, Yiu LSS (2017) Individualized homeopathic treatment in addition to conventional treatment in type II diabetic patients in Hong Kong—a retrospective cohort study. Homeopathy 106:79–86CrossRefGoogle Scholar
  3. 3.
    Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, Brähler E, Kiess W, Kapellen TM (2008) Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes 9:228–235CrossRefGoogle Scholar
  4. 4.
    Egede LE, Ye X, Zheng D, Silverstein MD (2002) The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25(2):324–329CrossRefGoogle Scholar
  5. 5.
    Chakraborti D, Mukherjee SC, Saha KC, Chowdhury UK, Rahman MM, Sengupta MK (2003) Arsenic toxicity from homeopathic treatment. J Toxicol Clin Toxicol 41:963–967CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.DiabetologyAzienda Ospedaliero-Universitaria Careggi and University of FlorenceFlorenceItaly

Personalised recommendations